ALLEGAN, MI (WHTC) - Perrigo officials announced yesterday quarterly earnings of over 119 million dollars, or a dollar-27 per share, up 15.6 percent from the same time frame a year ago. Net sales for the Allegan-based generic drug maker grew by more than six percent to nearly 770 million. Company executives say that new product sales from two firms acquired by Perrigo over the past 16 months accounted for 54 million in quarterly sales.